Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Gallagher John ECHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 12,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010062 · form4-04032024_090409.xml · derivative · entry 6 Gallagher John E · CIK 0001628991 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,266 Underlying: Common Stock · 12,632 shares Expires 2026-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. F3 · derivative.exercise_date: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Gallagher John ECHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010062 · form4-04032024_090409.xml · derivative · entry 5 Gallagher John E · CIK 0001628991 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,663 Underlying: Common Stock · 14,663 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU was granted on April 1, 2023, under the Certara, Inc. ("Certara") 2020 Incentive Plan (the "2020 Incentive Plan") and represents the right to receive one share of common stock or the cash equivalent. Half of the RSUs vested and were settled on April 1, 2024. The remaining RSUs are scheduled to vest and settle on April 1, 2025. F1 · derivative.exercise_date: Each RSU was granted on April 1, 2023, under the Certara, Inc. ("Certara") 2020 Incentive Plan (the "2020 Incentive Plan") and represents the right to receive one share of common stock or the cash equivalent. Half of the RSUs vested and were settled on April 1, 2024. The remaining RSUs are scheduled to vest and settle on April 1, 2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Gallagher John ECHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 4,327 | $17.88 | $77,366.76 |
DisclosureSEC source: 0001415889-24-010062 · form4-04032024_090409.xml · nonDerivative · entry 4 Gallagher John E · CIK 0001628991 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,218 F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes 1 and 3, exempt under Rule 16b-3. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Gallagher John ECHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 12,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010062 · form4-04032024_090409.xml · nonDerivative · entry 3 Gallagher John E · CIK 0001628991 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Gallagher John ECHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 4,750 | $17.88 | $84,930.00 |
DisclosureSEC source: 0001415889-24-010062 · form4-04032024_090409.xml · nonDerivative · entry 2 Gallagher John E · CIK 0001628991 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,913 F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes 1 and 3, exempt under Rule 16b-3. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:02 UTC |
Gallagher John ECHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 14,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010062 · form4-04032024_090409.xml · nonDerivative · entry 1 Gallagher John E · CIK 0001628991 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each RSU was granted on April 1, 2023, under the Certara, Inc. ("Certara") 2020 Incentive Plan (the "2020 Incentive Plan") and represents the right to receive one share of common stock or the cash equivalent. Half of the RSUs vested and were settled on April 1, 2024. The remaining RSUs are scheduled to vest and settle on April 1, 2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Exercise / conversionRestricted Stock Units · Derivative | 6,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010075 · form4-04032024_090439.xml · derivative · entry 8 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,288 Underlying: Common Stock · 6,644 shares Expires 2026-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. F5 · derivative.exercise_date: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Exercise / conversionRestricted Stock Units · Derivative | 6,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010075 · form4-04032024_090439.xml · derivative · entry 7 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,651 Underlying: Common Stock · 6,651 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. F4 · derivative.exercise_date: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
SaleCommon Stock | 3,000 | $18.00 | $54,000.00 |
DisclosureSEC source: 0001415889-24-010075 · form4-04032024_090439.xml · nonDerivative · entry 6 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,524 F6 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Tax withholdingCommon Stock | 2,276 | $17.88 | $40,694.88 |
DisclosureSEC source: 0001415889-24-010075 · form4-04032024_090439.xml · nonDerivative · entry 5 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 176,524 F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 6,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010075 · form4-04032024_090439.xml · nonDerivative · entry 4 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 178,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Tax withholdingCommon Stock | 2,245 | $17.88 | $40,140.60 |
DisclosureSEC source: 0001415889-24-010075 · form4-04032024_090439.xml · nonDerivative · entry 3 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 172,156 F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 6,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010075 · form4-04032024_090439.xml · nonDerivative · entry 2 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 174,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:08 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Tax withholdingCommon Stock | 1,723 | $17.88 | $30,807.24 |
DisclosureSEC source: 0001415889-24-010075 · form4-04032024_090439.xml · nonDerivative · entry 1 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,750 F1 · kind: Each RSU was granted on April 1, 2021, under the Certara, Inc. ("Certara") 2020 Incentive Plan (the "2020 Incentive Plan") and represents the right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2022. One-third of the RSUs vested and were settled on March 31, 2023. The remaining one-third of the RSUs vested and were settled on April 1, 2024. F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. F3 · balance_after: The total reported in Column 5 includes 5,495 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
GrantRestricted Stock Units · Derivative | 30,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010073 · form4-04032024_090432.xml · derivative · entry 8 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,381 Underlying: Common Stock · 30,381 shares Expires 2027-04-01 F6 · derivative.exercise_price: Each RSU was granted on April 1, 2024, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027. F6 · derivative.exercise_date: Each RSU was granted on April 1, 2024, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
Exercise / conversionRestricted Stock Units · Derivative | 7,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010073 · form4-04032024_090432.xml · derivative · entry 7 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,704 Underlying: Common Stock · 7,852 shares Expires 2026-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. F5 · derivative.exercise_date: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
Exercise / conversionRestricted Stock Units · Derivative | 8,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010073 · form4-04032024_090432.xml · derivative · entry 6 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,647 Underlying: Common Stock · 8,646 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. F4 · derivative.exercise_date: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
Tax withholdingCommon Stock | 2,690 | $17.88 | $48,097.20 |
DisclosureSEC source: 0001415889-24-010073 · form4-04032024_090432.xml · nonDerivative · entry 5 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,518 F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
Exercise / conversionCommon Stock | 7,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010073 · form4-04032024_090432.xml · nonDerivative · entry 4 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,208 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
Tax withholdingCommon Stock | 2,733 | $17.88 | $48,866.04 |
DisclosureSEC source: 0001415889-24-010073 · form4-04032024_090432.xml · nonDerivative · entry 3 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,356 F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
Exercise / conversionCommon Stock | 8,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010073 · form4-04032024_090432.xml · nonDerivative · entry 2 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
Tax withholdingCommon Stock | 1,532 | $17.88 | $27,392.16 |
DisclosureSEC source: 0001415889-24-010073 · form4-04032024_090432.xml · nonDerivative · entry 1 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,443 F1 · kind: Each RSU was granted on April 1, 2021, under the Certara, Inc. ("Certara") 2020 Incentive Plan (the "2020 Incentive Plan") and represents the right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2022. One-third of the RSUs vested and were settled on March 31, 2023. The remaining one-third of the RSUs vested and were settled on April 1, 2024. F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. F3 · balance_after: The total reported in Column 5 includes 4,884 RSUs which was previously reported in Table 1 of Form 4 Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
GrantRestricted Stock Units · Derivative | 30,381 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010061 · form4-04032024_090429.xml · derivative · entry 8 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,381 Underlying: Common Stock · 30,381 shares Expires 2027-04-01 F6 · derivative.exercise_price: Each RSU was granted on April 1, 2024, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027. F6 · derivative.exercise_date: Each RSU was granted on April 1, 2024, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Exercise / conversionRestricted Stock Units · Derivative | 7,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010061 · form4-04032024_090429.xml · derivative · entry 7 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,704 Underlying: Common Stock · 7,852 shares Expires 2026-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. F5 · derivative.exercise_date: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Exercise / conversionRestricted Stock Units · Derivative | 8,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010061 · form4-04032024_090429.xml · derivative · entry 6 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,647 Underlying: Common Stock · 8,646 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. F4 · derivative.exercise_date: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Tax withholdingCommon Stock | 3,691 | $17.88 | $65,995.08 |
DisclosureSEC source: 0001415889-24-010061 · form4-04032024_090429.xml · nonDerivative · entry 5 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,176 F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. F3 · balance_after: The total reported in Column 5 includes 7,937 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Exercise / conversionCommon Stock | 7,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010061 · form4-04032024_090429.xml · nonDerivative · entry 4 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,867 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · price: Each RSU was granted on April 1, 2023, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2024. The remaining two-thirds of the RSUs are scheduled to vest and settle in equal parts on April 1, 2025 and April 1, 2026. F3 · balance_after: The total reported in Column 5 includes 7,937 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Tax withholdingCommon Stock | 4,064 | $17.88 | $72,664.32 |
DisclosureSEC source: 0001415889-24-010061 · form4-04032024_090429.xml · nonDerivative · entry 3 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,015 F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. F3 · balance_after: The total reported in Column 5 includes 7,937 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Exercise / conversionCommon Stock | 8,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010061 · form4-04032024_090429.xml · nonDerivative · entry 2 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on March 31, 2023. One-third of the RSUs vested and were settled on April 1, 2024. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2025. F3 · balance_after: The total reported in Column 5 includes 7,937 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| April 01, 2024 Filed Apr 3, 2024 21:00 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Tax withholdingCommon Stock | 2,870 | $17.88 | $51,315.60 |
DisclosureSEC source: 0001415889-24-010061 · form4-04032024_090429.xml · nonDerivative · entry 1 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,433 F1 · kind: Each RSU was granted on April 1, 2021, under the Certara, Inc. ("Certara") 2020 Incentive Plan (the "2020 Incentive Plan") and represents the right to receive one share of common stock or the cash equivalent. One-third of the RSUs vested and were settled on April 1, 2022. One-third of the RSUs vested and were settled on March 31, 2023. The remaining one-third of the RSUs vested and were settled on April 1, 2024. F2 · shares: Represents RSUs of Certara withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes, 1, 4, and 5, exempt under Rule 16b-3. F3 · balance_after: The total reported in Column 5 includes 7,937 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| April 01, 2024 Filed Apr 5, 2024 20:23 UTC Amendment |
Feehery William FDirector · CHIEF EXECUTIVE OFFICER
|
GrantRestricted Stock Units · Derivative | 124,779 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-010404 · form4a-04052024_080451.xml · derivative · entry 1 Feehery William F · CIK 0001543193 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,779 Underlying: Common Stock · 124,779 shares Expires 2027-04-01 F1 · derivative.exercise_price: The original Form 4, filed on April 3, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that 120,981 restricted stock units ("RSUs") were granted on April 1, 2024, when in fact, 124,779 RSUs were granted. As a result of this update, the number of shares beneficially owned by the reporting person following such transaction has been correspondingly increased by 3,798 shares. As previously disclosed, each RSU was granted on April 1, 2024, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2025, April 1, 2026, and April 1, 2027. F1 · shares: The original Form 4, filed on April 3, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that 120,981 restricted stock units ("RSUs") were granted on April 1, 2024, when in fact, 124,779 RSUs were granted. As a result of this update, the number of shares beneficially owned by the reporting person following such transaction has been correspondingly increased by 3,798 shares. As previously disclosed, each RSU was granted on April 1, 2024, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2025, April 1, 2026, and April 1, 2027. F1 · derivative.exercise_date: The original Form 4, filed on April 3, 2024, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported that 120,981 restricted stock units ("RSUs") were granted on April 1, 2024, when in fact, 124,779 RSUs were granted. As a result of this update, the number of shares beneficially owned by the reporting person following such transaction has been correspondingly increased by 3,798 shares. As previously disclosed, each RSU was granted on April 1, 2024, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent. The RSUs will vest and settle in three equal installments on April 1, 2025, April 1, 2026, and April 1, 2027. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 16:36 UTC |
SHERMAN NICOLETTE DCHIEF HUMAN RESOURCES OFFICER
|
Tax withholdingCommon Stock | 2,373 | $18.88 | $44,802.24 |
DisclosureSEC source: 0001415889-24-007049 · form4-03062024_090320.xml · nonDerivative · entry 2 SHERMAN NICOLETTE D · CIK 0001872604 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,717 F2 · kind: Represents shares of the issuer withheld to satisfy tax withholding obligations in connection with the vesting of PSUs described in footnote 1. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 16:36 UTC |
SHERMAN NICOLETTE DCHIEF HUMAN RESOURCES OFFICER
|
GrantCommon Stock | 6,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007049 · form4-03062024_090320.xml · nonDerivative · entry 1 SHERMAN NICOLETTE D · CIK 0001872604 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,090 F1 · price: Each performance stock unit ("PSU") was granted on August 1, 2021, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock. The PSUs are subject to the achievement of certain performance objectives over a three-year period from January 1, 2021 to December 31, 2023. The PSUs were vested and settled on March 5, 2024. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:31 UTC |
Feehery William FDirector · CHIEF EXECUTIVE OFFICER
|
Tax withholdingCommon Stock | 17,557 | $18.88 | $331,476.16 |
DisclosureSEC source: 0001415889-24-007042 · form4-03062024_090352.xml · nonDerivative · entry 2 Feehery William F · CIK 0001543193 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,221,984 F2 · kind: Represents shares of the issuer withheld to satisfy tax withholding obligations in connection with the vesting of PSUs described in footnote 1. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:31 UTC |
Feehery William FDirector · CHIEF EXECUTIVE OFFICER
|
GrantCommon Stock | 59,799 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007042 · form4-03062024_090352.xml · nonDerivative · entry 1 Feehery William F · CIK 0001543193 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,239,541 F1 · price: Each performance stock unit ("PSU") was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock. The PSUs are subject to the achievement of certain performance objectives over a three-year period from January 1, 2021 to December 31, 2023. The PSUs were vested and settled on March 5, 2024. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:34 UTC |
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF
|
Tax withholdingCommon Stock | 4,050 | $18.88 | $76,464.00 |
DisclosureSEC source: 0001415889-24-007044 · form4-03062024_090307.xml · nonDerivative · entry 2 Pedersen Leif E · CIK 0001559712 · PRESIDENT, CHIEF COMMERCAL OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,381 F2 · kind: Represents shares of the issuer withheld to satisfy tax withholding obligations in connection with the vesting of PSUs described in footnote 1. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:34 UTC |
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF
|
GrantCommon Stock | 15,548 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007044 · form4-03062024_090307.xml · nonDerivative · entry 1 Pedersen Leif E · CIK 0001559712 · PRESIDENT, CHIEF COMMERCAL OFF 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,431 F1 · price: Each performance stock unit ("PSU") was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock. The PSUs are subject to the achievement of certain performance objectives over a three-year period from January 1, 2021 to December 31, 2023. The PSUs were vested and settled on March 5, 2024. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:39 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Tax withholdingCommon Stock | 3,660 | $18.88 | $69,100.80 |
DisclosureSEC source: 0001415889-24-007051 · form4-03062024_090348.xml · nonDerivative · entry 2 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,473 F2 · kind: Represents shares of the issuer withheld to satisfy tax withholding obligations in connection with the vesting of PSUs described in footnote 1. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:39 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
GrantCommon Stock | 10,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007051 · form4-03062024_090348.xml · nonDerivative · entry 1 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,133 F1 · price: Each performance stock unit ("PSU") was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock. The PSUs are subject to the achievement of certain performance objectives over a three-year period from January 1, 2021 to December 31, 2023. The PSUs were vested and settled on March 5, 2024. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:26 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Tax withholdingCommon Stock | 1,689 | $18.88 | $31,888.32 |
DisclosureSEC source: 0001415889-24-007036 · form4-03062024_090345.xml · nonDerivative · entry 4 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,303 F4 · kind: Represents shares of the issuer withheld to satisfy tax withholding obligations in connection with the vesting of PSUs described in footnote 3. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:26 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
GrantCommon Stock | 3,589 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007036 · form4-03062024_090345.xml · nonDerivative · entry 3 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 285,992 F3 · price: Each PSU was granted on July 1, 2021, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock. The PSUs are subject to the achievement of certain performance objectives over a three-year period from January 1, 2021 to December 31, 2023. The PSUs were vested and settled on March 5, 2024. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:26 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
Tax withholdingCommon Stock | 5,622 | $18.88 | $106,143.36 |
DisclosureSEC source: 0001415889-24-007036 · form4-03062024_090345.xml · nonDerivative · entry 2 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,403 F2 · kind: Represents shares of the issuer withheld to satisfy tax withholding obligations in connection with the vesting of PSUs described in footnote 1. Read SEC document |
| March 05, 2024 Filed Mar 6, 2024 21:26 UTC |
Aspbury RobertPRESIDENT; SCIENTIFIC SOFTWARE
|
GrantCommon Stock | 11,960 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007036 · form4-03062024_090345.xml · nonDerivative · entry 1 Aspbury Robert · CIK 0001834221 · PRESIDENT; SCIENTIFIC SOFTWARE 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,025 F1 · price: Each performance stock unit ("PSU") was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock. The PSUs are subject to the achievement of certain performance objectives over a three-year period from January 1, 2021 to December 31, 2023. The PSUs were vested and settled on March 5, 2024. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 21:45 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
SaleCommon Stock | 3,000 | $18.28 | $54,840.00 |
DisclosureSEC source: 0001415889-24-006739 · form4-03052024_090309.xml · nonDerivative · entry 1 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 162,368 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:40 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
SaleCommon Stock | 5,000 | $18.00 | $90,000.00 |
DisclosureSEC source: 0001415889-24-004633 · form4-02212024_090252.xml · nonDerivative · entry 1 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,975 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 20, 2023. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:33 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
SaleCommon Stock | 6,000 | $18.00 | $108,000.00 |
DisclosureSEC source: 0001415889-24-003750 · form4-02142024_090223.xml · nonDerivative · entry 1 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,368 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. Read SEC document |
| December 26, 2023 Filed Dec 27, 2023 23:36 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
SaleCommon Stock | 6,000 | $18.00 | $108,000.00 |
DisclosureSEC source: 0001415889-23-016967 · form4-12272023_111200.xml · nonDerivative · entry 1 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,368 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2023. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 21:07 UTC |
SMITH PATRICK FPRESIDENT, DRUG DEV SOLUTIONS
|
GrantRestricted Stock Units · Derivative | 21,454 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-014040 · form4-10062023_091052.xml · derivative · entry 1 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, DRUG DEV SOLUTIONS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,454 Underlying: Common Stock · 21,454 shares Expires 2026-10-05 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") was granted on October 5, 2023, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. The RSUs will vest and settle in three equal installments on October 5, 2024, October 5, 2025, and October 5, 2026. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") was granted on October 5, 2023, under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. The RSUs will vest and settle in three equal installments on October 5, 2024, October 5, 2025, and October 5, 2026. Read SEC document |
| September 11, 2023 Filed Sep 12, 2023 20:26 UTC |
Pedersen Leif EPRESIDENT, CHIEF COMMERCAL OFF
|
SaleCommon Stock | 51,224 | $14.60 | $747,870.40 |
DisclosureSEC source: 0001415889-23-013171 · form4-09122023_080947.xml · nonDerivative · entry 1 Pedersen Leif E · CIK 0001559712 · PRESIDENT, CHIEF COMMERCAL OFF 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 128,883 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2023. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.51 to $14.84. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 22, 2023 Filed Aug 23, 2023 20:38 UTC |
BROSHY ERANDirector
|
PurchaseCommon Stock | 4,807 | $15.80 | $75,950.60 |
DisclosureSEC source: 0001415889-23-012566 · form4-08232023_080847.xml · nonDerivative · entry 2 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,360 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.